ENHYPEN has proven its global popularity by ranking on the U.S. Billboard main album chart, the Billboard 200, for four consecutive weeks with its 8th mini album 'THE SIN : BLISS'.

The album ranked 115th on the chart dated September 26. Earlier, 'THE SIN : BLISS' entered the Billboard 200 at No. 1 on the September 5 chart and remained on the chart for a month.

Its detailed chart performance is also notable. 'THE SIN : BLISS' ranked 2nd in the World Albums category and 4th in Top Album Sales. The title track 'Bloody Paradise' also ranked 182nd on Billboard's Global (Excl. U.S.) chart for four weeks. Accordingly, ENHYPEN ranked 58th on the Artist 100 chart.

The album's sales and certification records are also impressive. Upon its release on August 21, the album recorded 2.09 million copies in first-week sales, becoming ENHYPEN's fifth double-million seller. In addition, as of August, its cumulative shipments in Japan exceeded 250,000 copies, earning Platinum certification from the Recording Industry Association of Japan.

Meanwhile, ENHYPEN is currently conducting its world tour 'ENHYPEN WORLD TOUR 'BLOOD SAGA'' with a total of 37 performances in 22 cities. After wrapping up its Macao concert in October, the group will continue with a four-dome tour of Japan from December through February next year, followed by performances across Asia and Europe through March next year.